Author

Y Chua

Observed name: Y.J. Chua

Observed institutions: Serdang Hospital, James Cook University Hospital

OpenAlex ID: A5110737465

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

560 Case Report: A Very Rare Case of Incidentaloma of a Large Adrenal Cavernous Haemangioma

2021 · Y Chua, S Quake, et al. · British journal of surgery

Clinical audit on administration of parenteral antibiotics within one hour of recognition of medical septic shock patients

2020 · S. Kamaludeen, Y.J. Chua · International Journal of Infectious Diseases

Works count: 6

Citation count: 92

H-index: 3

I10-index: 3